EU Innovation Network (EU-IN)
Submitted by Anonymous (not verified) on 15 July 2026 - 10:10
EU Innovation Network (EU-IN)
Severe cutaneous adverse reactions - standard template wording for product information
Submitted by Anonymous (not verified) on 15 July 2026 - 10:00
Severe cutaneous adverse reactions - standard template wording for product information
Scientific advice and protocol assistance adopted during the CHMP meeting 22-25 June 2026
Submitted by Anonymous (not verified) on 15 July 2026 - 9:45
Scientific advice and protocol assistance adopted during the CHMP meeting 22-25 June 2026
List of substances and products subject to worksharing for signal management
Submitted by Anonymous (not verified) on 15 July 2026 - 8:39
List of substances and products subject to worksharing for signal management
PSUSA/00002275/202512
Submitted by Anonymous (not verified) on 15 July 2026 - 8:35
PSUSA/00002275/202512
PSUSA/00002801/202511
Submitted by Anonymous (not verified) on 15 July 2026 - 8:19
PSUSA/00002801/202511
Meeting report of the EMA cancer medicines forum 14 November 2025
Submitted by Anonymous (not verified) on 14 July 2026 - 16:40
Meeting report of the EMA cancer medicines forum 14 November 2025
Veterinary medicines European public assessment report (EPAR): Poulvac Procerta HVT-ND, Marek’s disease and Newcastle disease vaccine (live recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 14 July 2026 - 15:16
Veterinary medicines European public assessment report (EPAR): Poulvac Procerta HVT-ND, Marek’s disease and Newcastle disease vaccine (live recombinant), Status: Authorised
EMA/PE/0000235924
Submitted by Anonymous (not verified) on 14 July 2026 - 14:58
EMA/PE/0000235924
EMA/PE/0000240621
Submitted by Anonymous (not verified) on 14 July 2026 - 14:54
EMA/PE/0000240621